Stockreport

Precision Therapeutics Receives $1,370,000 Investment from CEO and Director, Carl Schwartz

PRECISION THERAPEUTICS INC COMMON  (AIPT) 
US:NASDAQ Investor Relations: investors.skylinemedical.com/investor-relations
PDF MINNEAPOLIS, Jan. 18, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announced that its chief executive offic [Read more]